|
|
|
|
|
文献清单:肝脏病学2024-2025精选文章| MDPI Livers |
|
|
期刊名:Livers
期刊主页:https://www.mdpi.com/journal/livers
本期编辑荐读为您精选Livers期刊中18篇2024-2025年热门文章,希望能为各位肝病学领域专家提供最受欢迎的研究进展!
1. Liver and Vascular Involvement in Philadelphia-Negative Chronic Myeloproliferative Neoplasms—A Narrative Review
费城染色体阴性慢性骨髓增生性肿瘤的肝脏和血管受累——叙述性综述
http://www.mdpi.com/2673-4389/5/3/29
Mihaila, R.G.; Todor, S.B.; Mihaila, M.D. Liver and Vascular Involvement in Philadelphia-Negative Chronic Myeloproliferative Neoplasms—A Narrative Review. Livers 2025, 5, 29. https://doi.org/10.3390/livers5030029
2. Exploring the Role of Probiotics, Prebiotics, and Synbiotics in the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease—A Scoping Review
探索益生菌、益生元和合生元在代谢功能障碍相关脂肪肝疾病治疗中的作用——一项范围综述
http://www.mdpi.com/2673-4389/5/3/31
Ntikoudi, A.; Papachristou, A.; Spirou, A.; Evangelou, E.; Tsartsalis, A.; Vlachou, E.; Mastorakos, G. Exploring the Role of Probiotics, Prebiotics, and Synbiotics in the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease—A Scoping Review. Livers 2025, 5, 31. https://doi.org/10.3390/livers5030031
3. Synthalin, Buformin, Phenformin, and Metformin: A Century of Intestinal “Glucose Excretion” as Oral Antidiabetic Strategy in Overweight/Obese Patients
合成酶、丁福明、苯乙双胍和二甲双胍:一个世纪以来肠道“葡萄糖排泄”作为超重/肥胖患者口服降糖策略的应用
http://www.mdpi.com/2673-4389/5/3/35
Ramadori, G.P. Synthalin, Buformin, Phenformin, and Metformin: A Century of Intestinal “Glucose Excretion” as Oral Antidiabetic Strategy in Overweight/Obese Patients. Livers 2025, 5, 35. https://doi.org/10.3390/livers5030035
4. Serum Level of Glypican-3 in Patients with Hepatocellular Carcinoma and Advanced Chronic Liver Disease: A Pilot Study
肝细胞癌和晚期慢性肝病患者血清中糖蛋白聚糖-3水平:一项初步研究
http://www.mdpi.com/2673-4389/5/3/36
Ivanova, I.; Banova-Chakyrova, S.; Boykova-Vylcheva, P.; Bocheva, Y. Serum Level of Glypican-3 in Patients with Hepatocellular Carcinoma and Advanced Chronic Liver Disease: A Pilot Study. Livers 2025, 5, 36. https://doi.org/10.3390/livers5030036
5. Palliative Care in End-Stage Liver Disease
终末期肝病的姑息治疗
http://www.mdpi.com/2673-4389/5/3/39
Sousa, L.; Silva, S.M.; Rego, F.; Nunes, R.; Oliveira, H.M. Palliative Care in End-Stage Liver Disease. Livers 2025, 5, 39. https://doi.org/10.3390/livers5030039
6. Hepatotoxicity of Herbal and Dietary Supplements a Review of Diagnosis, Histologic Features, and Common Culprits: Bodybuilding and Weight Loss Supplements
草药和膳食补充剂的肝毒性:诊断、组织学特征和常见致病因素综述——健美和减肥补充剂
http://www.mdpi.com/2673-4389/5/3/42
Marginean, E.C. Hepatotoxicity of Herbal and Dietary Supplements a Review of Diagnosis, Histologic Features, and Common Culprits: Bodybuilding and Weight Loss Supplements. Livers 2025, 5, 42. https://doi.org/10.3390/livers5030042
7. Comparison of Liver Venous Deprivation Versus Portal Vein Embolization in Patients with Liver Malignancies: A Systematic Review
肝恶性肿瘤患者肝静脉剥夺与门静脉栓塞术的比较:系统评价
http://www.mdpi.com/2673-4389/5/4/48
Papakonstantinou, M.; Gkaitatzi, A.D.; Chatzikomnitsa, P.; Papagiannis, V.; Papadopoulos, V.N.; Giakoustidis, A.; Giakoustidis, D. Comparison of Liver Venous Deprivation Versus Portal Vein Embolization in Patients with Liver Malignancies: A Systematic Review. Livers 2025, 5, 48. https://doi.org/10.3390/livers5040048
8. Evaluating NSQIP Outcomes According to the Clavien–Dindo Classification: A Model to Estimate Global Outcome Measures Following Hepatopancreaticobiliary Surgery
根据Clavien-Dindo分级评估NSQIP结果:肝胆胰手术后总体结果指标的估计模型
http://www.mdpi.com/2673-4389/5/4/50
Verhoeff, K.; Jatana, S.; Irfan, A.; Sapisochin, G. Evaluating NSQIP Outcomes According to the Clavien–Dindo Classification: A Model to Estimate Global Outcome Measures Following Hepatopancreaticobiliary Surgery. Livers 2025, 5, 50. https://doi.org/10.3390/livers5040050
9. Effect of Oral Vitamin D Overdose in Male and Female Wistar Rats with Induced MASLD
口服维生素D过量对诱导MASLD的雄性和雌性Wistar大鼠的影响
http://www.mdpi.com/2673-4389/5/4/52
Muller de Moura Sarmento, S.; Erminda Schreiner, G.; Smolski dos Santos, L.; Berny Pereira, C.; Gomes Schmitt, E.; Tejada Nunes, V.; Tamborena Malheiros, R.; Klock, C.; Casanova Petry, C.; Gonçalves, I.L.; et al. Effect of Oral Vitamin D Overdose in Male and Female Wistar Rats with Induced MASLD. Livers 2025, 5, 52. https://doi.org/10.3390/livers5040052
10. Undiagnosed Liver Disease in Patients with Late-Stage Hepatocellular Carcinoma
晚期肝细胞癌患者中未确诊的肝病
http://www.mdpi.com/2673-4389/5/4/57
Ngoi, B.; Kaur, H.; Lane, A.; Nitchingham, D.; Norozi, A.; Sukocheva, O.; Pietris, K.; Morgan, J.; Flores, J.E.; Tse, E. Undiagnosed Liver Disease in Patients with Late-Stage Hepatocellular Carcinoma. Livers 2025, 5, 57. https://doi.org/10.3390/livers5040057
11. Targeted Liver Fibrosis Therapy: Evaluating Retinol-Modified Nanoparticles and Atorvastatin/JQ1-Loaded Nanoparticles for Deactivation of Activated Hepatic Stellate Cells
靶向肝纤维化治疗:评估视黄醇修饰纳米粒与载阿托伐他汀 / JQ1 纳米粒对活化肝星状细胞的失活作用
http://www.mdpi.com/2673-4389/5/4/63
Ezzat, A.A.; Tammam, S.N.; Weiskirchen, R.; Schröder-Lange, S.K.; Mansour, S. Targeted Liver Fibrosis Therapy: Evaluating Retinol-Modified Nanoparticles and Atorvastatin/JQ1-Loaded Nanoparticles for Deactivation of Activated Hepatic Stellate Cells. Livers 2025, 5, 63. https://doi.org/10.3390/livers5040063
12. Secondary Perfusion to Model Viability of Livers Declined for Transplantation
二次灌注模拟移植失败肝脏的存活能力
http://www.mdpi.com/2673-4389/5/4/66
Fortier, A.K.; Feeney, K.M.; Holzner, M.L.; DiNorcia, J.; Shapiro, R.; Kim-Schluger, L.; Florman, S.S.; van Leeuwen, L.L.; Akhtar, M.Z. Secondary Perfusion to Model Viability of Livers Declined for Transplantation. Livers 2025, 5, 66. https://doi.org/10.3390/livers5040066
13. Role of Mitochondrial Iron Uptake in Acetaminophen Hepatotoxicity
线粒体铁摄取在对乙酰氨基酚肝毒性中的作用
http://www.mdpi.com/2673-4389/4/3/24
Hu, J.; Nieminen, A.-L.; Zhong, Z.; Lemasters, J.J. Role of Mitochondrial Iron Uptake in Acetaminophen Hepatotoxicity. Livers 2024, 4, 333-351. https://doi.org/10.3390/livers4030024
14. Resmetirom: Finally, the Light at the End of the NASH Tunnel?
雷司替罗:终于迎来 NASH 治疗隧道尽头的曙光?
http://www.mdpi.com/2673-4389/4/1/10
Lonardo, A. Resmetirom: Finally, the Light at the End of the NASH Tunnel? Livers 2024, 4, 138-141. https://doi.org/10.3390/livers4010010
15. Functions and Therapeutic Use of Heat Shock Proteins in Hepatocellular Carcinoma
热休克蛋白在肝细胞癌中的功能和治疗应用
http://www.mdpi.com/2673-4389/4/1/11
Paul, R.; Shreya, S.; Pandey, S.; Shriya, S.; Abou Hammoud, A.; Grosset, C.F.; Prakash Jain, B. Functions and Therapeutic Use of Heat Shock Proteins in Hepatocellular Carcinoma. Livers 2024, 4, 142-163. https://doi.org/10.3390/livers4010011
16. Glycyrrhizinic Acid and Phosphatidylcholine Combination as a Preventive Therapy for Experimental Murine Non-Alcoholic Steatohepatitis
甘草酸和磷脂酰胆碱联合用药作为实验性小鼠非酒精性脂肪性肝炎的预防性治疗
http://www.mdpi.com/2673-4389/4/1/6
Prikhodko, V.A.; Matuzok, T.M.; Karev, V.E.; Karavaeva, A.V.; Spasenkova, O.M.; Kirillova, N.V.; Ivkin, D.Y.; Okovityi, S.V. Glycyrrhizinic Acid and Phosphatidylcholine Combination as a Preventive Therapy for Experimental Murine Non-Alcoholic Steatohepatitis. Livers 2024, 4, 63-83. https://doi.org/10.3390/livers4010006
17. Minimally Invasive Surgery in Liver Transplantation: From Living Liver Donation to Graft Implantation
肝移植中的微创手术:从活体肝脏捐献到移植物植入
http://www.mdpi.com/2673-4389/4/1/9
Avramidou, E.; Terlemes, K.; Lymperopoulou, A.; Katsanos, G.; Antoniadis, N.; Kofinas, A.; Vasileiadou, S.; Karakasi, K.-E.; Tsoulfas, G. Minimally Invasive Surgery in Liver Transplantation: From Living Liver Donation to Graft Implantation. Livers 2024, 4, 119-137. https://doi.org/10.3390/livers4010009
18. Understanding the Liver’s Role in the Clearance of Aβ40
肝脏在 Aβ40 清除中的作用机制研究
http://www.mdpi.com/2673-4389/4/2/18
Lockwood, G.P.; Hunt, N.J.; Kockx, M.; Kang, S.W.S.; Le Couteur, D.G.; Cogger, V.C. Understanding the Liver’s Role in the Clearance of Aβ40. Livers 2024, 4, 253-267. https://doi.org/10.3390/livers4020018
期刊简介
期刊主题涵盖肝炎所有形式;酒精性肝病;非酒精性脂肪性肝病和非酒精性脂性肝炎;肝硬化;胆道疾病;药物性肝损伤;遗传性和代谢性肝病及其并发症;癌症与药物代谢;肝细胞癌;肝纤维化;肝病免疫学;肝病学营养;肝病病理学;肝病的诊断和治疗,为肝病学多学科领域的基础、转化和高级临床研究提供平台。目前已被 ESCI(Web of Science)、Scopus 等国际权威数据库收录。
|
2024 Impact Factor
|
2.4
|
|
2024 CiteScore
|
3.2
|
|
Time to First Decision
|
27 days
|
|
Time to Publication
|
6.7 days
|
|
|
主编: Prof. Dr. Hartmut W. Jaeschke
University of Kansas Medical Center, Kansas City, KS 66160, USA
|
|
|
副主编:Prof. Dr. Ralf Weiskirchen
RWTH University Hospital Aachen, D-52074 Aachen, Germany
|
特别声明:本文转载仅仅是出于传播信息的需要,并不意味着代表本网站观点或证实其内容的真实性;如其他媒体、网站或个人从本网站转载使用,须保留本网站注明的“来源”,并自负版权等法律责任;作者如果不希望被转载或者联系转载稿费等事宜,请与我们接洽。